Nedaplatin (INN, marketed under the tradename Aqupla) is a platinum compound which is used for cancer chemotherapy.[1] It produces less nausea, vomiting and nephrotoxicity than other platinum-containing drugs.[2]
References [edit]
- ^ Wheate, Nial J.; Walker, Shonagh; Craig, Gemma E.; Oun, Rabbab (2010). "The status of platinum anticancer drugs in the clinic and in clinical trials". Dalton Transactions 39 (35): 8113–27. doi:10.1039/C0DT00292E. PMID 20593091.
- ^ Ota K (February 1996). "[Nedaplatin]". Gan to Kagaku Ryoho (in Japanese) 23 (3): 379–87. PMID 8712835.
- (Japanese) Aqupla アクプラ (PDF) Shionogi & Co. March 2007.
External links [edit]
|
|
|
| Pt(0) |
|
|
| Pt(II) |
|
|
| Pt(IV) |
|
|
| Pt(V) |
|
|
| Pt(IV,VI) |
|
|
| Pt(VI) |
|
|
(what is this?) (verify)
